Cellectar Biosciences Inc - Company Profile

Powered by

All the sales intelligence you need on Cellectar Biosciences Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Cellectar Biosciences Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Cellectar Biosciences Inc.

Back to companies

Cellectar Biosciences Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Cellectar Biosciences Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4248999A3 Search Report Ether-phospholipid-verbindungen zur krebsbehandlung sowie zur abbildung und erkennung von krebsstammzellen A61K45/06; A61P13/08; A61P13/12; A61P15/00; A61P35/04; A61P1/00; A61P1/18; A61K51/0489; A61K51/0408; A61P17/00; A61N2005/1021; A61P43/00; A61N5/1001; A61P11/00; A61P25/00; A61P35/00; A61K31/661; C07B59/00; A61K31/685; A61N5/02 November 15, 2023
DK3708192T3 Application Etherphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller A61K31/685; A61N2005/1021; A61N5/02; A61P13/08; A61K51/0489; A61N5/1001; A61P17/00; C07B59/00; A61P1/00; A61P1/18; A61P35/00; A61P11/00; A61P25/00; A61K51/0408; A61P43/00; A61K45/06; A61K31/661; A61P13/12; A61P15/00; A61P35/04 November 06, 2023
ES2952867T3 Grant Análogos de éteres de fosfolípidos para la identificación y aislamiento de células tumorales circulantes G01N15/14; G01N2015/0065; G01N2015/1006; G01N2015/1402; G01N2015/1488; G01N2021/6439; G01N21/6428; G01N33/54326; G01N33/574; G01N33/57492; G01N33/582; G01R33/1269 November 06, 2023
EP4041320A4 Search Report Fractionated dosing of a phospholipid ether analog for the treatment of cancer A61K51/0408; A61P35/00 November 01, 2023
SI3469367T1 Grant Phospholipid ether analogs for the identification and isolation of circulating tumor cells G01N15/14; G01N2015/0065; G01N2015/1006; G01N2015/1402; G01N2015/1488; G01N2021/6439; G01N21/6428; G01N33/54326; G01N33/574; G01N33/57492; G01N33/582; G01R33/1269 October 30, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer